Login Register Cart 0
Generic placeholder image

Current Cardiology Reviews

Editor-in-Chief

ISSN (Print): 1573-403X
ISSN (Online): 1875-6557

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

Concise Review of the Rationale for Pulmonary Embolism Treatment and Endovascular Device Therapies

Author(s): Caleb Chiang* and Steve Attanasio

Volume 18, Issue 3, 2022

Published on: 13 January, 2022

Article ID: e261121198323 Pages: 11

DOI: 10.2174/1573403X17666211126092110

open access plus

Abstract

In the ever-changing landscape of device therapy for pulmonary embolism, it is important to understand the rationale behind the ongoing explosion in the development of new device therapies. There needs to be an in-depth understanding of risk stratification in pulmonary embolism and indications for therapy. Selecting the ideal device for a particular pulmonary embolism subset remains elusive and poorly defined. Knowledge of the risks, benefits, capabilities, and potential limitations of each device is crucial.

Keywords: Pulmonary embolism, catheter-directed thrombolysis, mechanical thrombectomy, thrombolysis, ultrasound-assisted thrombolysis, PERT.

Graphical Abstract

[1]
van Langevelde K, Srámek A, Vincken PW, van Rooden JK, Rosendaal FR, Cannegieter SC. Finding the origin of pulmonary emboli with a total-body magnetic resonance direct thrombus imaging technique. Haematologica 2013; 98(2): 309-15.
[http://dx.doi.org/10.3324/haematol.2012.069195] [PMID: 22801962]
[2]
The Surgeon General’s call to action to prevent deep vein thrombosis and pulmonary embolism. Rockville, MD: U.S. Public Health Service. Office of the Surgeon General 2008.
[3]
Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: Are we detecting enough deep vein thrombosis? J R Soc Med 1989; 82(4): 203-5.
[http://dx.doi.org/10.1177/014107688908200407] [PMID: 2716016]
[4]
Rubinstein I, Murray D, Hoffstein V. Fatal pulmonary emboli in hospitalized patients. An autopsy study. Arch Intern Med 1988; 148(6): 1425-6.
[http://dx.doi.org/10.1001/archinte.1988.00380060189033] [PMID: 3377625]
[5]
Giri J, Sista AK, Weinberg I, et al. Interventional therapies for acute pulmonary embolism: current status and principles for the development of novel evidence: A scientific statement from the American Heart Association. Circulation 2019; 140(20): e774-801.
[http://dx.doi.org/10.1161/CIR.0000000000000707] [PMID: 31585051]
[6]
Grosse SD, Nelson RE, Nyarko KA, Richardson LC, Raskob GE. The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs. Thromb Res 2016; 137: 3-10.
[http://dx.doi.org/10.1016/j.thromres.2015.11.033] [PMID: 26654719]
[7]
Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J 2019; 54(3): 1901647.
[http://dx.doi.org/10.1183/13993003.01647-2019] [PMID: 31473594]
[8]
Schultz J, Giordano N, Zheng H, et al. EXPRESS: A multidisciplinary pulmonary embolism response team (PERT) - experience from a national multicenter consortium. Pulm Circ 2019; 9(3): 2045894018824563.
[http://dx.doi.org/10.1177/2045894018824563] [PMID: 30632901]
[9]
Prandoni P. Acquired risk factors for venous thromboembolism in medical patients. Hematology (Am Soc Hematol Educ Program) 2005; 458-61.
[http://dx.doi.org/10.1182/asheducation-2005.1.458] [PMID: 16304420]
[10]
Spencer FA, Emery C, Lessard D, et al. The Worcester Venous Thromboembolism study: A population-based study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med 2006; 21(7): 722-7.
[http://dx.doi.org/10.1111/j.1525-1497.2006.00458.x] [PMID: 16808773]
[11]
Goldhaber SZ, Grodstein F, Stampfer MJ, et al. A prospective study of risk factors for pulmonary embolism in women. JAMA 1997; 277(8): 642-5.
[http://dx.doi.org/10.1001/jama.1997.03540320044033] [PMID: 9039882]
[12]
Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ III. Risk factors for deep vein thrombosis and pulmonary embolism: A population-based case-control study. Arch Intern Med 2000; 160(6): 809-15.
[http://dx.doi.org/10.1001/archinte.160.6.809] [PMID: 10737280]
[13]
Liu Y, Cai J, Wang C, Jin J, Qu L. Incidence, prognosis, and laboratory indicators of venous thromboembolism in hospitalized patients with coronavirus disease 2019: A systematic review and meta-analysis. J Vasc Surg Venous Lymphat Disord 2021.
[http://dx.doi.org/10.1016/j.jvsv.2021.01.012] [PMID: 33529719]
[14]
Hotoleanu C. Genetic risk factors in venous thromboembolism. Adv Exp Med Biol 2017; 906: 253-72.
[http://dx.doi.org/10.1007/5584_2016_120] [PMID: 27638626]
[15]
Crowther MA, Kelton JG. Congenital thrombophilic states associated with venous thrombosis: A qualitative overview and proposed classification system. Ann Intern Med 2003; 138(2): 128-34.
[http://dx.doi.org/10.7326/0003-4819-138-2-200301210-00014] [PMID: 12529095]
[16]
Mateo J, Oliver A, Borrell M, Sala N, Fontcuberta J. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism-results of the Spanish Multicentric Study on Thrombophilia (EMET-Study). Thromb Haemost 1997; 77(3): 444-51.
[http://dx.doi.org/10.1055/s-0038-1655986] [PMID: 9065991]
[17]
Girard P, Decousus M, Laporte S, et al. Diagnosis of pulmonary embolism in patients with proximal deep vein thrombosis: specificity of symptoms and perfusion defects at baseline and during anticoagulant therapy. Am J Respir Crit Care Med 2001; 164(6): 1033-7.
[http://dx.doi.org/10.1164/ajrccm.164.6.2101045] [PMID: 11587992]
[18]
Weitz JI, Fredenburgh JC, Eikelboom JW. A test in context: D-dimer. J Am Coll Cardiol 2017; 70(19): 2411-20.
[http://dx.doi.org/10.1016/j.jacc.2017.09.024] [PMID: 29096812]
[19]
Stein PD, Hull RD, Patel KC, et al. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: A systematic review. Ann Intern Med 2004; 140(8): 589-602.
[http://dx.doi.org/10.7326/0003-4819-140-8-200404200-00005] [PMID: 15096330]
[20]
Konstantinides S, Geibel A, Olschewski M, et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 2002; 106(10): 1263-8.
[http://dx.doi.org/10.1161/01.CIR.0000028422.51668.A2] [PMID: 12208803]
[21]
Verschuren F, Bonnet M, Benoit MO, et al. The prognostic value of pro-B-Type natriuretic peptide in acute pulmonary embolism. Thromb Res 2013; 131(6): e235-9.
[http://dx.doi.org/10.1016/j.thromres.2013.03.009] [PMID: 23562569]
[22]
Kucher N, Goldhaber SZ. Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism. Circulation 2003; 108(18): 2191-4.
[http://dx.doi.org/10.1161/01.CIR.0000100687.99687.CE] [PMID: 14597581]
[23]
Kurnicka K, Lichodziejewska B, Goliszek S, et al. Echocardiographic pattern of acute pulmonary embolism: Analysis of 511 consecutive patients. J Am Soc Echocardiogr 2016; 29(9): 907-13.
[http://dx.doi.org/10.1016/j.echo.2016.05.016] [PMID: 27427291]
[24]
Da Costa Rodrigues J, Alzuphar S, Combescure C, Le Gal G, Perrier A. Diagnostic characteristics of lower limb venous compression ultrasonography in suspected pulmonary embolism: A meta-analysis. J Thromb Haemost 2016; 14(9): 1765-72.
[http://dx.doi.org/10.1111/jth.13407] [PMID: 27377039]
[25]
Le Gal G, Righini M, Sanchez O, et al. A positive compression ultrasonography of the lower limb veins is highly predictive of pulmonary embolism on computed tomography in suspected patients. Thromb Haemost 2006; 95(6): 963-6.
[http://dx.doi.org/10.1160/TH06-03-0158] [PMID: 16732375]
[26]
Shopp JD, Stewart LK, Emmett TW, Kline JA. Findings from 12-lead electrocardiography that predict circulatory shock from pulmonary embolism: systematic review and meta-analysis. Acad Emerg Med 2015; 22(10): 1127-37.
[http://dx.doi.org/10.1111/acem.12769] [PMID: 26394330]
[27]
Qaddoura A, Digby GC, Kabali C, Kukla P, Zhan ZQ, Baranchuk AM. The value of electrocardiography in prognosticating clinical deterioration and mortality in acute pulmonary embolism: A systematic review and meta-analysis. Clin Cardiol 2017; 40(10): 814-24.
[http://dx.doi.org/10.1002/clc.22742] [PMID: 28628222]
[28]
Wells PS, Anderson DR, Rodger M, et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Ann Intern Med 2001; 135(2): 98-107.
[http://dx.doi.org/10.7326/0003-4819-135-2-200107170-00010] [PMID: 11453709]
[29]
Wolf SJ, McCubbin TR, Feldhaus KM, Faragher JP, Adcock DM. Prospective validation of Wells Criteria in the evaluation of patients with suspected pulmonary embolism. Ann Emerg Med 2004; 44(5): 503-10.
[http://dx.doi.org/10.1016/j.annemergmed.2004.04.002] [PMID: 15520710]
[30]
Klok FA, Kruisman E, Spaan J, et al. Comparison of the revised Geneva score with the Wells rule for assessing clinical probability of pulmonary embolism. J Thromb Haemost 2008; 6(1): 40-4.
[http://dx.doi.org/10.1111/j.1538-7836.2007.02820.x] [PMID: 17973649]
[31]
Kline JA, Mitchell AM, Kabrhel C, Richman PB, Courtney DM. Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism. J Thromb Haemost 2004; 2(8): 1247-55.
[http://dx.doi.org/10.1111/j.1538-7836.2004.00790.x] [PMID: 15304025]
[32]
Penaloza A, Soulié C, Moumneh T, et al. Pulmonary embolism rule-out criteria (PERC) rule in European patients with low implicit clinical probability (PERCEPIC): A multicentre, prospective, observational study. Lancet Haematol 2017; 4(12): e615-21.
[http://dx.doi.org/10.1016/S2352-3026(17)30210-7] [PMID: 29150390]
[33]
Stein PD, Fowler SE, Goodman LR, et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med 2006; 354(22): 2317-27.
[http://dx.doi.org/10.1056/NEJMoa052367] [PMID: 16738268]
[34]
Waxman AD, Bajc M, Brown M, et al. Appropriate use criteria for ventilation-perfusion imaging in pulmonary embolism: summary and excerpts. J Nucl Med 2017; 58(5): 13N-5N.
[PMID: 28461589]
[35]
Anderson DR, Kahn SR, Rodger MA, et al. Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: A randomized controlled trial. JAMA 2007; 298(23): 2743-53.
[http://dx.doi.org/10.1001/jama.298.23.2743] [PMID: 18165667]
[36]
Donzé J, Le Gal G, Fine MJ, et al. Prospective validation of the Pulmonary Embolism Severity Index. A clinical prognostic model for pulmonary embolism. Thromb Haemost 2008; 100(5): 943-8.
[http://dx.doi.org/10.1160/TH08-05-0285] [PMID: 18989542]
[37]
Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005; 172(8): 1041-6.
[http://dx.doi.org/10.1164/rccm.200506-862OC] [PMID: 16020800]
[38]
Righini M, Roy PM, Meyer G, Verschuren F, Aujesky D, Le Gal G. The Simplified Pulmonary Embolism Severity Index (PESI): validation of a clinical prognostic model for pulmonary embolism. J Thromb Haemost 2011; 9(10): 2115-7.
[http://dx.doi.org/10.1111/j.1538-7836.2011.04469.x] [PMID: 21848693]
[39]
Jiménez D, Aujesky D, Moores L, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 2010; 170(15): 1383-9.
[http://dx.doi.org/10.1001/archinternmed.2010.199] [PMID: 20696966]
[40]
Yamashita Y, Morimoto T, Amano H, et al. Validation of simplified PESI score for identification of low-risk patients with pulmonary embolism: From the COMMAND VTE Registry. Eur Heart J Acute Cardiovasc Care 2020; 9(4): 262-70.
[http://dx.doi.org/10.1177/2048872618799993] [PMID: 30203659]
[41]
Elias A, Mallett S, Daoud-Elias M, Poggi JN, Clarke M. Prognostic models in acute pulmonary embolism: A systematic review and meta-analysis. BMJ Open 2016; 6(4): e010324-4.
[http://dx.doi.org/10.1136/bmjopen-2015-010324] [PMID: 27130162]
[42]
Jaff MR, McMurtry MS, Archer SL, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: A scientific statement from the American Heart Association. Circulation 2011; 123(16): 1788-830.
[http://dx.doi.org/10.1161/CIR.0b013e318214914f] [PMID: 21422387]
[43]
Cossette B, Pelletier ME, Carrier N, et al. Evaluation of bleeding risk in patients exposed to therapeutic unfractionated or low- molecular-weight heparin: A cohort study in the context of a quality improvement initiative. Ann Pharmacother 2010; 44(6): 994-1002.
[http://dx.doi.org/10.1345/aph.1M615] [PMID: 20442353]
[44]
Büller HR, Davidson BL, Decousus H, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 2003; 349(18): 1695-702.
[http://dx.doi.org/10.1056/NEJMoa035451] [PMID: 14585937]
[45]
Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2)(Suppl.): e419S-96S.
[http://dx.doi.org/10.1378/chest.11-2301] [PMID: 22315268]
[46]
Sharifi M, Bay C, Skrocki L, Rahimi F, Mehdipour M. Moderate pulmonary embolism treated with thrombolysis (from the “MOPETT” Trial). Am J Cardiol 2013; 111(2): 273-7.
[http://dx.doi.org/10.1016/j.amjcard.2012.09.027] [PMID: 23102885]
[47]
Wang C, Zhai Z, Yang Y, et al. Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: A randomized, multicenter, controlled trial. Chest 2010; 137(2): 254-62.
[http://dx.doi.org/10.1378/chest.09-0765] [PMID: 19741062]
[48]
Dalla-Volta S, Palla A, Santolicandro A, et al. PAIMS 2: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J Am Coll Cardiol 1992; 20(3): 520-6.
[http://dx.doi.org/10.1016/0735-1097(92)90002-5] [PMID: 1512328]
[49]
Konstantinides S, Tiede N, Geibel A, Olschewski M, Just H, Kasper W. Comparison of alteplase versus heparin for resolution of major pulmonary embolism. Am J Cardiol 1998; 82(8): 966-70.
[http://dx.doi.org/10.1016/S0002-9149(98)00513-X] [PMID: 9794353]
[50]
Marti C, John G, Konstantinides S, et al. Systemic thrombolytic therapy for acute pulmonary embolism: A systematic review and meta-analysis. Eur Heart J 2015; 36(10): 605-14.
[http://dx.doi.org/10.1093/eurheartj/ehu218] [PMID: 24917641]
[51]
Meyer G, Vicaut E, Danays T, et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 2014; 370(15): 1402-11.
[http://dx.doi.org/10.1056/NEJMoa1302097] [PMID: 24716681]
[52]
Fasullo S, Scalzo S, Maringhini G, et al. Six-month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction: comparison of thrombolysis with heparin. Am J Med Sci 2011; 341(1): 33-9.
[http://dx.doi.org/10.1097/MAJ.0b013e3181f1fc3e] [PMID: 20890176]
[53]
Konstantinides S, Geibel A, Olschewski M, et al. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry. Circulation 1997; 96(3): 882-8.
[http://dx.doi.org/10.1161/01.CIR.96.3.882] [PMID: 9264496]
[54]
Chatterjee S, Chakraborty A, Weinberg I, et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: A meta-analysis. JAMA 2014; 311(23): 2414-21.
[http://dx.doi.org/10.1001/jama.2014.5990] [PMID: 24938564]
[55]
Sista AK, Bhatheja R, Rali P, et al. First-in-human study to assess the safety and feasibility of the Bashir endovascular catheter for the treatment of acute intermediate-risk pulmonary embolism. Circ Cardiovasc Interv 2021; 14(1): e009611.
[http://dx.doi.org/10.1161/CIRCINTERVENTIONS.120.009611] [PMID: 33356383]
[56]
tPA by endovascular administration for the treatment of submassive PE using CDT for the reduction of thrombus burden. Thrombolex Inc 2020. Available from: https://clinicaltrials.gov/ct2/show/NCT04248868 [cited 1 Apr 2021].
[57]
Kuo WT, van den Bosch MAAJ, Hofmann LV, Louie JD, Kothary N, Sze DY. Catheter-directed embolectomy, fragmentation, and thrombolysis for the treatment of massive pulmonary embolism after failure of systemic thrombolysis. Chest 2008; 134(2): 250-4.
[http://dx.doi.org/10.1378/chest.07-2846] [PMID: 18682455]
[58]
Patel N, Patel NJ, Agnihotri K, et al. Utilization of catheter-directed thrombolysis in pulmonary embolism and outcome difference between systemic thrombolysis and catheter-directed thrombolysis. Catheter Cardiovasc Interv 2015; 86(7): 1219-27.
[http://dx.doi.org/10.1002/ccd.26108] [PMID: 26308961]
[59]
Kuo WT, Banerjee A, Kim PS, et al. Pulmonary embolism response to fragmentation, embolectomy, and catheter thrombolysis (PERFECT): initial results from a prospective multicenter registry. Chest 2015; 148(3): 667-73.
[http://dx.doi.org/10.1378/chest.15-0119] [PMID: 25856269]
[60]
Braaten JV, Goss RA, Francis CW. Ultrasound reversibly disaggregates fibrin fibers. Thromb Haemost 1997; 78(3): 1063-8.
[http://dx.doi.org/10.1055/s-0038-1657688] [PMID: 9308755]
[61]
Kucher N, Boekstegers P, Müller OJ, et al. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation 2014; 129(4): 479-86.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.113.005544] [PMID: 24226805]
[62]
Piazza G, Hohlfelder B, Jaff MR, et al. A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low- dose fibrinolysis for acute massive and submassive pulmonary embolism: the SEATTLE II study. JACC Cardiovasc Interv 2015; 8(10): 1382-92.
[http://dx.doi.org/10.1016/j.jcin.2015.04.020] [PMID: 26315743]
[63]
Tapson VF, Sterling K, Jones N, et al. A randomized trial of the optimum duration of acoustic pulse thrombolysis procedure in acute intermediate-risk pulmonary embolism: the OPTALYSE PE trial. JACC Cardiovasc Interv 2018; 11(14): 1401-10.
[http://dx.doi.org/10.1016/j.jcin.2018.04.008] [PMID: 30025734]
[64]
Pei DT, Liu J, Yaqoob M, et al. Meta-analysis of catheter directed ultrasound-assisted thrombolysis in pulmonary embolism. Am J Cardiol 2019; 124(9): 1470-7.
[http://dx.doi.org/10.1016/j.amjcard.2019.07.040] [PMID: 31492420]
[65]
Rothschild DP, Goldstein JA, Ciacci J, Bowers TR. Ultrasound-accelerated thrombolysis (USAT) versus standard catheter-directed thrombolysis (CDT) for treatment of pulmonary embolism: A retrospective analysis. Vasc Med 2019; 24(3): 234-40.
[http://dx.doi.org/10.1177/1358863X19838350] [PMID: 30915912]
[66]
Rao G, Xu H, Wang JJ, et al. Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute pulmonary embolism: A multicenter comparison of patient-centered outcomes. Vasc Med 2019; 24(3): 241-7.
[http://dx.doi.org/10.1177/1358863X19838334] [PMID: 30915914]
[67]
Avgerinos ED, Mohapatra A, Rivera-Lebron B, et al. Design and rationale of a randomized trial comparing standard versus ultrasound-assisted thrombolysis for submassive pulmonary embolism. J Vasc Surg Venous Lymphat Disord 2018; 6(1): 126-32.
[http://dx.doi.org/10.1016/j.jvsv.2017.09.004] [PMID: 29248101]
[68]
SUNSET sPE trial compares standard versus ultrasound-assisted thrombolysis to treat submassive pulmonary embolism. 2020. Available from: https://evtoday.com/news/sunset-spe-trial-compares-standard-versus-ultrasound-assisted-thrombolysis-to-treat- submassive-pulmonary-embolism [cited 4 Apr 2021].
[69]
Pronto® XL extraction catheter. 2021. Available from: https://fda.report/GUDID/M20650610 [cited 13 Feb 2021].
[70]
Heberlein WE, Meek ME, Saleh O, Meek JC, Lensing SY, Culp WC. New generation aspiration catheter: Feasibility in the treatment of pulmonary embolism. World J Radiol 2013; 5(11): 430-5.
[http://dx.doi.org/10.4329/wjr.v5.i11.430] [PMID: 24349647]
[71]
Dumantepe M, Teymen B, Akturk U, Seren M. Efficacy of rotational thrombectomy on the mortality of patients with massive and submassive pulmonary embolism. J Card Surg 2015; 30(4): 324-32.
[http://dx.doi.org/10.1111/jocs.12521] [PMID: 25683156]
[72]
Basman C, Rashid U, Parmar YJ, Kliger C, Kronzon I. The role of percutaneous vacuum-assisted thrombectomy for intracardiac and intravascular pathology. J Card Surg 2018; 33(10): 666-72.
[http://dx.doi.org/10.1111/jocs.13806] [PMID: 30187515]
[73]
Donaldson CW, Baker JN, Narayan RL, et al. Thrombectomy using suction filtration and veno-venous bypass: single center experience with a novel device. Catheter Cardiovasc Interv 2015; 86(2): E81-7.
[http://dx.doi.org/10.1002/ccd.25583] [PMID: 24975395]
[74]
Salsamendi J, Doshi M, Bhatia S, et al. Single center experience with the AngioVac aspiration system. Cardiovasc Intervent Radiol 2015; 38(4): 998-1004.
[http://dx.doi.org/10.1007/s00270-015-1152-x] [PMID: 26067804]
[75]
Al-Hakim R, Park J, Bansal A, Genshaft S, Moriarty JM. Early experience with AngioVac aspiration in the pulmonary arteries. J Vasc Interv Radiol 2016; 27(5): 730-4.
[http://dx.doi.org/10.1016/j.jvir.2016.01.012] [PMID: 27106647]
[76]
Ciampi-Dopazo JJ, Romeu-Prieto JM, Sánchez-Casado M, et al. Aspiration thrombectomy for treatment of acute massive and submassive pulmonary embolism: initial single-center prospective experience. J Vasc Interv Radiol 2018; 29(1): 101-6.
[http://dx.doi.org/10.1016/j.jvir.2017.08.010] [PMID: 29102272]
[77]
Al-Hakim R, Bhatt A, Benenati JF. Continuous aspiration mechanical thrombectomy for the management of submassive pulmonary embolism: A single-center experience. J Vasc Interv Radiol 2017; 28(10): 1348-52.
[http://dx.doi.org/10.1016/j.jvir.2017.06.025] [PMID: 28941516]
[78]
Pieraccini M, Guerrini S, Laiolo E, et al. Acute massive and submassive pulmonary embolism: preliminary validation of aspiration mechanical thrombectomy in patients with contraindications to thrombolysis. Cardiovasc Intervent Radiol 2018; 41(12): 1840-8.
[http://dx.doi.org/10.1007/s00270-018-2011-3] [PMID: 29980817]
[79]
Sista AK, Horowitz JM, Tapson VF, et al. Indigo aspiration system for treatment of pulmonary embolism: results of the EXTRACT-PE trial. JACC Cardiovasc Interv 2021; 14(3): 319-29.
[http://dx.doi.org/10.1016/j.jcin.2020.09.053] [PMID: 33454291]
[80]
Mojibian HR, Chow E, Pollak J. FlowTriever System for mechanical thromboembolectomy. Future Cardiol 2021; 17(4): 585-92.
[http://dx.doi.org/10.2217/fca-2020-0104] [PMID: 33084387]
[81]
Tu T, Toma C, Tapson VF, et al. A prospective, single-arm, multicenter trial of catheter-directed mechanical thrombectomy for intermediate-risk acute pulmonary embolism: the FLARE study. JACC Cardiovasc Interv 2019; 12(9): 859-69.
[http://dx.doi.org/10.1016/j.jcin.2018.12.022] [PMID: 31072507]
[82]
Wible BC, Buckley JR, Cho KH, Bunte MC, Saucier NA, Borsa JJ. Safety and efficacy of acute pulmonary embolism treated via large-bore aspiration mechanical thrombectomy using the Inari FlowTriever device. J Vasc Interv Radiol 2019; 30(9): 1370-5.
[http://dx.doi.org/10.1016/j.jvir.2019.05.024] [PMID: 31375449]
[83]
Toma C, Khandhar S, Zalewski AM, D’Auria SJ, Tu TM, Jaber WA. Percutaneous thrombectomy in patients with massive and very high-risk submassive acute pulmonary embolism. Catheter Cardiovasc Interv 2020; 96(7): 1465-70.
[http://dx.doi.org/10.1002/ccd.29246] [PMID: 32866345]
[84]
Yasin JT, Davis R, Saemi A, et al. Technical efficiency, short-term clinical results and safety of a large-bore aspiration catheter in acute pulmonary embolism - A retrospective case study. Lung India 2020; 37(6): 485-90.
[http://dx.doi.org/10.4103/lungindia.lungindia_115_20] [PMID: 33154209]
[85]
Toma C. Interim acute and 30-day results of the Flash registry. Circulation 2020; 142(Suppl. 3): A16623.
[http://dx.doi.org/10.1161/circ.142.suppl_3.16623]
[86]
FlowTriever all-comer registry for patient safety and hemodynamics. Inari Medical 2018. Available from: https://clinicaltrials.gov/ct2/show/study/NCT03761173 [cited 4 Apr 2021].
[87]
Bonvini RF, Roffi M, Bounameaux H, et al. AngioJet rheolytic thrombectomy in patients presenting with high-risk pulmonary embolism and cardiogenic shock: A feasibility pilot study. EuroIntervention 2013; 8(12): 1419-27.
[http://dx.doi.org/10.4244/EIJV8I12A215] [PMID: 23680957]
[88]
Chechi T, Vecchio S, Spaziani G, et al. Rheolytic thrombectomy in patients with massive and submassive acute pulmonary embolism. Catheter Cardiovasc Interv 2009; 73(4): 506-13.
[http://dx.doi.org/10.1002/ccd.21858] [PMID: 19235240]
[89]
Das S, Das N, Serota H, Vissa S. A retrospective review of patients with massive and submassive pulmonary embolism treated with AngioJet rheolytic thrombectomy with decreased complications due to changes in thrombolytic use and procedural modifications. Vascular 2018; 26(2): 163-8.
[http://dx.doi.org/10.1177/1708538117722728] [PMID: 28828935]
[90]
Margheri M, Vittori G, Vecchio S, et al. Early and long-term clinical results of AngioJet rheolytic thrombectomy in patients with acute pulmonary embolism. Am J Cardiol 2008; 101(2): 252-8.
[http://dx.doi.org/10.1016/j.amjcard.2007.07.087] [PMID: 18178417]
[91]
Zeni PT Jr, Blank BG, Peeler DW. Use of rheolytic thrombectomy in treatment of acute massive pulmonary embolism. J Vasc Interv Radiol 2003; 14(12): 1511-5.
[http://dx.doi.org/10.1097/01.RVI.0000099526.29957.EF] [PMID: 14654484]
[92]
Chauhan MS, Kawamura A. Percutaneous rheolytic thrombectomy for large pulmonary embolism: A promising treatment option. Catheter Cardiovasc Interv 2007; 70(1): 121-8.
[http://dx.doi.org/10.1002/ccd.20997] [PMID: 17421019]
[93]
Büller HR, Prins MH, Lensin AW, et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 2012; 366(14): 1287-97.
[http://dx.doi.org/10.1056/NEJMoa1113572] [PMID: 22449293]
[94]
Liu X, Johnson M, Mardekian J, Phatak H, Thompson J, Cohen AT. Apixaban reduces hospitalizations in patients with venous thromboembolism: An analysis of the apixaban for the initial management of pulmonary embolism and deep-vein thrombosis as first-line therapy (AMPLIFY) trial. J Am Heart Assoc 2015; 4(12): e002340.
[http://dx.doi.org/10.1161/JAHA.115.002340] [PMID: 26627879]
[95]
Goldhaber SZ, Schellong S, Kakkar A, et al. Treatment of acute pulmonary embolism with dabigatran versus warfarin. A pooled analysis of data from RE-COVER and RE-COVER II. Thromb Haemost 2016; 116(4): 714-21.
[PMID: 27411591]
[96]
Piazza G, Sterling KM, Tapson VF, et al. One-year echocardiographic, functional, and quality of life outcomes after ultrasound- facilitated catheter-based fibrinolysis for pulmonary embolism. Circ Cardiovasc Interv 2020; 13(8): e009012.
[http://dx.doi.org/10.1161/CIRCINTERVENTIONS.120.009012] [PMID: 32757658]
[97]
Sista AK, Klok FA. Late outcomes of pulmonary embolism: The post-PE syndrome. Thromb Res 2018; 164: 157-62.
[http://dx.doi.org/10.1016/j.thromres.2017.06.017] [PMID: 28641836]
[98]
Pesavento R, Filippi L, Palla A, et al. Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism. Eur Respir J 2017; 49(5): 1601980.
[http://dx.doi.org/10.1183/13993003.01980-2016] [PMID: 28546279]

Rights & Permissions Print Cite
Article Metrics
46
1
© 2024 Bentham Science Publishers | Privacy Policy